Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.

Saved in:
Bibliographic Details
Title: Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.
Authors: Ribas A; University of California Los Angeles (UCLA) and Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, USA. aribas@mednet.ucla.edu., Algazi A; UCSF Medical Center, San Francisco, CA, USA., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Butler MO; Princess Margaret Cancer Centre, Toronto, ON, Canada., Chandra S; Northwestern Memorial Hospital, Chicago, IL, USA., Gordon M; HonorHealth Research Institute, Scottsdale, AZ, USA., Hernandez-Aya L; Washington University School of Medicine, St. Louis, MO, USA., Lawrence D; Massachusetts General Hospital, Boston, MA, USA., Lutzky J; Mount Sinai Medical Center, Miami Beach, FL, USA., Miller WH Jr; Segal Cancer Center, Jewish General Hospital, Rossy Cancer Network, McGill University, Montreal, QC, Canada., Campbell KM; University of California Los Angeles (UCLA) and Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, USA., Delafont B; AstraZeneca, Gaithersburg, MD, USA., Marshall S; AstraZeneca, Gaithersburg, MD, USA., Mueller N; AstraZeneca, Gaithersburg, MD, USA., Robert C; Gustave Roussy Cancer Campus and Paris-Saclay University, Villejuif, France.
Source: Nature communications [Nat Commun] 2021 Aug 12; Vol. 12 (1), pp. 5022. Date of Electronic Publication: 2021 Aug 12.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-021-25285-0